Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. freshman Avg
|
New words:
Avenue, Box, Cover, Data, deficit, Floor, Flow, formatted, Grand, House, Inline, Interactive, iv, Jersey, Language, made, matching, sixty, Ugland, York
Removed:
Brady, Calculation, Designation, exempted, Extension, Instance, Label, Linkbase, Presentation, Schema, Taxonomy
Filing tables
Filing exhibits
Associated PLXPQ transcripts
PLXPQ similar filings
Filing view
External links
Exhibit 31.3
CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Natasha Giordano, certify that:
1. | I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of PLx Pharma Inc.; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: April 29, 2022 | /s/ Natasha Giordano | ||
Natasha Giordano | |||
President and | |||
Chief Executive Officer | |||
(principal executive officer) |